New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes. Issue 5 (20th January 2022)
- Record Type:
- Journal Article
- Title:
- New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes. Issue 5 (20th January 2022)
- Main Title:
- New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes
- Authors:
- Kameyama, Komei
Imai, Kazuhiro
Ishiyama, Koichi
Takashima, Shinogu
Kuriyama, Shoji
Atari, Maiko
Ishii, Yoshiaki
Kobayashi, Akihito
Takahashi, Shugo
Kobayashi, Mirai
Harata, Yuzu
Sato, Yusuke
Motoyama, Satoru
Hashimoto, Manabu
Nomura, Kyoko
Minamiya, Yoshihiro - Abstract:
- Abstract: Background: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique to improve nodal staging using preoperative PET/CT in patients with resectable lung cancer. Methods: Preoperative PET/CT findings (pStage IB–III 182 patients) and pathological diagnoses after surgical resection were evaluated. Using PET/CT images to determine the standardized uptake value (SUV) ratio, the SUVmax of a contralateral hilar lymph node (on the side of the chest opposite to the primary tumor) was measured simultaneously. The I/C‐SUV ratio was calculated as ipsilateral hilar node SUV/contralateral hilar node SUV. Receiver operating characteristic (ROC) curves were then used to analyze those data. Results: Based on ROC analyses, the cutoff I/C‐SUV ratio for diagnosis of lymph node metastasis was 1.34. With a tumor ipsilateral lymph node SUVmax ≥2.5, an IC‐SUV ratio ≥1.34 had the highest accuracy for predicting N1/N2 metastasis; the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of nodal staging were 60.66, 85.11, 84.09, 62.5 and 71.29%, respectively. Conclusions: When diagnosing nodal stage, a lymph node I/C‐SUV ratio ≥1.34 can be an effective criterion for determining surgical indications in advanced lung cancer. Abstract : In a situation where bilateral N1 nodes are not enlarged but 18 F fluorodeoxyglucose uptake is high in PET/CT, nodal staging must be assessedAbstract: Background: The aim of the present study was to use surgical and histological results to develop a simple noninvasive technique to improve nodal staging using preoperative PET/CT in patients with resectable lung cancer. Methods: Preoperative PET/CT findings (pStage IB–III 182 patients) and pathological diagnoses after surgical resection were evaluated. Using PET/CT images to determine the standardized uptake value (SUV) ratio, the SUVmax of a contralateral hilar lymph node (on the side of the chest opposite to the primary tumor) was measured simultaneously. The I/C‐SUV ratio was calculated as ipsilateral hilar node SUV/contralateral hilar node SUV. Receiver operating characteristic (ROC) curves were then used to analyze those data. Results: Based on ROC analyses, the cutoff I/C‐SUV ratio for diagnosis of lymph node metastasis was 1.34. With a tumor ipsilateral lymph node SUVmax ≥2.5, an IC‐SUV ratio ≥1.34 had the highest accuracy for predicting N1/N2 metastasis; the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of nodal staging were 60.66, 85.11, 84.09, 62.5 and 71.29%, respectively. Conclusions: When diagnosing nodal stage, a lymph node I/C‐SUV ratio ≥1.34 can be an effective criterion for determining surgical indications in advanced lung cancer. Abstract : In a situation where bilateral N1 nodes are not enlarged but 18 F fluorodeoxyglucose uptake is high in PET/CT, nodal staging must be assessed intraoperatively. New I/C SUV ratio ≥1.34, which calculated as ipsilateral/contralateral hilar node standardized uptake value, improved clinical nodal staging even in this situation. I/C ratio has the potential to resolve the misinterpretation as cancer progression by bilateral diffuse FDG (pseudo‐) activity due to chronic inflammation. … (more)
- Is Part Of:
- Thoracic cancer. Volume 13:Issue 5(2022)
- Journal:
- Thoracic cancer
- Issue:
- Volume 13:Issue 5(2022)
- Issue Display:
- Volume 13, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 13
- Issue:
- 5
- Issue Sort Value:
- 2022-0013-0005-0000
- Page Start:
- 708
- Page End:
- 715
- Publication Date:
- 2022-01-20
- Subjects:
- computed tomography -- lung cancer -- lymph node -- metastasis -- positron‐emission tomography
Chest -- Cancer -- Periodicals
Chest -- Cancer -- Treatment -- Periodicals
Chest -- Surgery -- Periodicals
616.99494005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1111/%28ISSN%291759-7714;jsessionid=9202029487E02D838DF722140677202D.d04t01 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1759-7714 ↗
http://onlinelibrary.wiley.com/ ↗
http://www.wiley.com/bw/journal.asp?ref=1759-7706&site=1 ↗ - DOI:
- 10.1111/1759-7714.14302 ↗
- Languages:
- English
- ISSNs:
- 1759-7706
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8820.242500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21817.xml